A subcommittee of the FDA tobacco advisory committee is meeting on June 8 and 9.
Articles written by numerous individuals, copies of which are posted on this page , took strong exception with some of the appointments to the full committee because of alleged conflicts.
FDA should publish immediately the name of the Chair of the aforementioned subcommitee, a list of the other members of the committee and their scientific backgrounds accompanied be a web accessible list of their publications.
Upon publication of the said material, CRE will publish the information on this site for public comment.
In the mean time, CRE would welcome your views on this matter by clicking on the “comments” tab below.